Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.2243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long-Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Two Brothers With Skewed Thiopurine Metabolism in Ulcerative Colitis Treated Successfully With Allopurinol and Mercaptopurine Dose Reduction

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Bronchiolitis in a Patient With Ulcerative Colitis Treated With Erythromycin

Internal Medicine
Internal MedicineMedicine
2014English

IBS-like Symptoms in Patients With Ulcerative Colitis

Clinical and Experimental Gastroenterology
Gastroenterology
2015English

Dramatic Improvement of Severe Acne Pustolosa After Adalimumab in a Patient With Ulcerative Colitis

Clinical Case Reports
Medicine
2016English

Adalimumab for Ulcerative Colitis: Results of a Brazilian Multicenter Observational Study

Arquivos de Gastroenterologia
Gastroenterology
2017English

Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis

Cost Effectiveness and Resource Allocation
Health Policy
2009English

Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Prognostic Factors Affecting Early Colectomy in Patients With Moderate to Severe Ulcerative Colitis Treated With Calcineurin Inhibitors

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy